vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.
Vitesse Energy, Inc. is the larger business by last-quarter revenue ($58.6M vs $37.2M, roughly 1.6× GYRE THERAPEUTICS, INC.). Vitesse Energy, Inc. runs the higher net margin — -1.3% vs -3.7%, a 2.4% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 4.8%). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs -2.1%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.
GYRE vs VTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $58.6M |
| Net Profit | $-1.4M | $-739.0K |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | -12.0% |
| Net Margin | -3.7% | -1.3% |
| Revenue YoY | 33.4% | 4.8% |
| Net Profit YoY | -340.1% | 85.6% |
| EPS (diluted) | $-0.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $58.6M | ||
| Q3 25 | $30.6M | $67.4M | ||
| Q2 25 | $26.8M | $81.8M | ||
| Q1 25 | $22.1M | $66.2M | ||
| Q4 24 | $27.9M | $55.9M | ||
| Q3 24 | $25.5M | $58.3M | ||
| Q2 24 | $25.2M | $66.6M | ||
| Q1 24 | $27.2M | $61.2M |
| Q4 25 | $-1.4M | $-739.0K | ||
| Q3 25 | $5.9M | $-1.3M | ||
| Q2 25 | $1.6M | $24.7M | ||
| Q1 25 | $3.7M | $2.7M | ||
| Q4 24 | $569.0K | $-5.1M | ||
| Q3 24 | $2.9M | $17.4M | ||
| Q2 24 | $4.5M | $10.9M | ||
| Q1 24 | $9.9M | $-2.2M |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | -12.0% | ||
| Q3 25 | 22.7% | 0.2% | ||
| Q2 25 | 8.1% | 22.8% | ||
| Q1 25 | 10.3% | 8.1% | ||
| Q4 24 | 2.4% | 3.7% | ||
| Q3 24 | 16.6% | 15.4% | ||
| Q2 24 | 12.7% | 25.2% | ||
| Q1 24 | 29.7% | 21.4% |
| Q4 25 | -3.7% | -1.3% | ||
| Q3 25 | 19.4% | -1.9% | ||
| Q2 25 | 5.9% | 30.2% | ||
| Q1 25 | 16.9% | 4.0% | ||
| Q4 24 | 2.0% | -9.2% | ||
| Q3 24 | 11.2% | 29.9% | ||
| Q2 24 | 18.0% | 16.4% | ||
| Q1 24 | 36.6% | -3.6% |
| Q4 25 | $-0.01 | $-0.01 | ||
| Q3 25 | $0.03 | $-0.03 | ||
| Q2 25 | $0.00 | $0.60 | ||
| Q1 25 | $0.00 | $0.08 | ||
| Q4 24 | $0.00 | $-0.15 | ||
| Q3 24 | $0.01 | $0.53 | ||
| Q2 24 | $0.01 | $0.33 | ||
| Q1 24 | $0.03 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.0M | $629.3M |
| Total Assets | $166.1M | $893.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $54.4M | — | ||
| Q1 25 | $29.9M | $4.5M | ||
| Q4 24 | $26.7M | $3.0M | ||
| Q3 24 | $25.1M | — | ||
| Q2 24 | $25.1M | — | ||
| Q1 24 | $37.4M | — |
| Q4 25 | $106.0M | $629.3M | ||
| Q3 25 | $101.9M | $650.3M | ||
| Q2 25 | $92.0M | $671.9M | ||
| Q1 25 | $68.1M | $667.7M | ||
| Q4 24 | $63.3M | $500.3M | ||
| Q3 24 | $63.2M | $520.4M | ||
| Q2 24 | $60.4M | $518.5M | ||
| Q1 24 | $56.6M | $522.7M |
| Q4 25 | $166.1M | $893.4M | ||
| Q3 25 | $159.4M | $932.9M | ||
| Q2 25 | $152.6M | $951.5M | ||
| Q1 25 | $129.8M | $975.2M | ||
| Q4 24 | $125.4M | $810.9M | ||
| Q3 24 | $125.2M | $791.2M | ||
| Q2 24 | $120.9M | $778.4M | ||
| Q1 24 | $122.0M | $749.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $37.4M |
| Free Cash FlowOCF − Capex | $-5.8M | — |
| FCF MarginFCF / Revenue | -15.5% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $37.4M | ||
| Q3 25 | $4.7M | $49.4M | ||
| Q2 25 | $2.1M | $66.0M | ||
| Q1 25 | $-129.0K | $17.5M | ||
| Q4 24 | $-2.8M | $34.7M | ||
| Q3 24 | $1.7M | $45.7M | ||
| Q2 24 | $-5.5M | $35.2M | ||
| Q1 24 | $2.9M | $39.4M |
| Q4 25 | $-5.8M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $-251.0K | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $2.7M | — |
| Q4 25 | -15.5% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -10.1% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | -27.5% | — | ||
| Q1 24 | 9.8% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 1.32× | 2.68× | ||
| Q1 25 | -0.03× | 6.56× | ||
| Q4 24 | -4.85× | — | ||
| Q3 24 | 0.60× | 2.62× | ||
| Q2 24 | -1.21× | 3.22× | ||
| Q1 24 | 0.29× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GYRE
Segment breakdown not available.
VTS
| Oil Reserves | $54.5M | 93% |
| Natural Gas Reserves | $4.2M | 7% |
